Cancer Center AssociatesMar 8, 20212 min readFDA Approves Libtayo for NSCLC With High PD-L1 ExpressionLibtayo is now approved for the first-line treatment of patients. Call our team at 972-548-9690 to see if this treatment is right for you.
Dr. Amanullah Khan MDMar 8, 20211 min readTAGRISSO- New Indications for Non Small Cell Lung Cancer!New treatment options for resectable EGFRm Non-Small Cell Lung Cancer—Tagrisso: Convenient, once-daily dosing, taken at home.
Dr. Farhan Mohammad MDSep 23, 20201 min readAcute promyelocytic leukemia (APL) in a patient with Crohn's disease and exposure to infliximab: a A very rare and possibly one of the few case reports of acute promyelocytic leukemia (APL; acute myeloid leukemia M3, AML-M3) to be reported
Dr. Farhan Mohammad MDSep 23, 20203 min readComposite Diffuse Large B-cell and Mantle Cell Lymphoma: A Case ReportComposite lymphoma is an extremely rare clinical entity.
Cancer Center AssociatesSep 23, 20201 min readPatients' Experience with Dr. KhanU. S. News & World Report When choosing a provider, it can be helpful to review other patients' experiences. U.S. News publishes patient...
Dr. Farhan Mohammad MDSep 23, 20202 min readTestosterone Levels and Quality of Life in Diverse Male Patients With Cancers Unrelated to AndrogensSymptoms secondary to hormonal changes significantly impact quality of life (QoL) in patients with cancer.
Dr. Amanullah Khan MDApr 18, 20201 min readNew drug approval by FDA for MDS related anemiaOn April 3, 2020, the Food and Drug Administration approved new treatment for MDS related anemia.
Cancer Center AssociatesApr 7, 20201 min readOur Response to COVID-19We are making a few changes to our standard process. Here are the instructions for coming to the office during the COVID-19 pandemic.